Thus, miR-142-3p directly targets HMGA1, HMGA2, HMGB1, and HMGB3, inhibiting them through reduction of cell viability, colony formation, migration, and invasion, as well as induction of apoptosis of tumor cells, particularly cervical cancer cells [209]. Here, HMGB3 is linked to cervical cancer.